Merck KGaA (MKKGY) Expected to Announce Earnings on Wednesday

Merck KGaA (OTCMKTS:MKKGY) is expected to release its resultson Wednesday, May 13th. Analysts expect Merck KGaA to post earnings of $0.45 per share and revenue of $5.9425 billion for the quarter.

Merck KGaA (OTCMKTS:MKKGY) last issued its quarterly earnings data on Thursday, March 5th. The company reported $0.28 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.19). The business had revenue of $6.11 billion during the quarter, compared to the consensus estimate of $6.20 billion. Merck KGaA had a return on equity of 9.03% and a net margin of 12.31%. On average, analysts expect Merck KGaA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Merck KGaA Price Performance

Shares of MKKGY stock opened at $26.01 on Wednesday. The firm has a market cap of $16.81 billion, a P/E ratio of 11.56, a P/E/G ratio of 2.32 and a beta of 0.97. Merck KGaA has a fifty-two week low of $23.73 and a fifty-two week high of $31.00. The business’s 50 day moving average price is $26.31 and its 200-day moving average price is $27.52. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.96 and a current ratio of 1.46.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on MKKGY. Sanford C. Bernstein upgraded Merck KGaA to a “hold” rating in a research report on Thursday, March 19th. Deutsche Bank Aktiengesellschaft lowered Merck KGaA from a “buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. Four investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, Merck KGaA currently has a consensus rating of “Hold”.

About Merck KGaA

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.